Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.82% | $1.03B | €413.15B | 48.58% | 76 Outperform | |
| Roche Holding AG | 1.12% | $632.02M | CHF272.24B | 45.48% | 73 Outperform | |
| AstraZeneca | 1.08% | $609.09M | £220.41B | 29.45% | 80 Outperform | |
| HSBC Holdings | 1.03% | $583.77M | £205.11B | 49.44% | 80 Outperform | |
| Novartis AG | 1.03% | $579.97M | CHF217.04B | 25.19% | 80 Outperform | |
| SAP SE | 0.94% | $530.70M | €241.78B | -14.21% | 66 Neutral | |
| Royal Bank Of Canada | 0.90% | $510.32M | $236.46B | 43.18% | 75 Outperform | |
| Nestlé SA | 0.89% | $501.95M | CHF190.59B | 15.67% | 71 Outperform | |
| Toyota Motor | 0.85% | $479.25M | ¥44.16T | 14.07% | 80 Outperform | |
| Siemens | 0.82% | $465.52M | €198.34B | 29.64% | 74 Outperform |